The Acute Respiratory Distress Syndrome (ARDS) Market is set to experience significant transformation, with a projected market size expansion from $5.88 billion in 2024 to approximately $11.9 billion by 2035. This represents a compound annual growth rate (CAGR) of 6.62%, underlining the escalating demand for advanced therapeutic solutions and innovative healthcare technologies. The implications...